Inductive logo
Real-World Evidence

Evidence Generation

We design and deliver robust real-world evidence strategies that support regulatory, payer, HTA, and clinical decision-making across the product lifecycle.

patternpattern
RWE
OUR APPROACH

How We Generate Decision-Grade Real-World Evidence

Real-world evidence must do more than describe what happened in practice. It must answer a clearly defined stakeholder question with scientific rigor, transparent methodology, and data that is fit for purpose.

Our approach begins with the decision that evidence needs to support, whether for regulatory, market access, payer, HTA, safety, comparative effectiveness, or clinical use. We then design the right study strategy, identify and curate the most relevant data sources, and apply robust analytical methods to generate credible, actionable insights.

By combining domain expertise in epidemiology, biostatistics, clinical research, data management, and analytics, we help sponsors transform real-world data into evidence that is relevant, defensible, and ready for decision-making.

Generation Framework

Strategy & Design
Define the right research question and study approach.
Data & Analytics
Curate, validate, and analyze relevant real-world data.
Reporting & Impact
Translate findings into clear, decision-ready evidence.
OUR CORE CAPABILITIES

End-to-End Real-World Evidence Capabilities

We combine strategy, epidemiology, biostatistics, HEOR, safety, and regulatory expertise to generate decision-grade evidence across the product lifecycle.

Evidence Strategy & Study Design

  • Define the research question, study design, endpoints, comparators, and evidence plan aligned to stakeholder needs.

Data Curation & Harmonization

  • Curate, standardize, and validate real-world data from EHR, claims, registries, PROs, and other sources for fit-for-purpose use.

Analytics Pipelines & Evidence Generation

  • Build reproducible analytical workflows that transform curated data into credible, decision-ready evidence.

Comparative Effectiveness & Outcomes Research

  • Evaluate real-world treatment performance using robust methods for comparative and outcomes-based evidence generation.

Post-Authorization & Safety Studies

  • Support long-term safety, effectiveness, and regulatory commitments through post-authorization evidence generation.

Market Access, HTA & Specialty Evidence

  • Generate evidence that supports payer, HTA, reimbursement, and specialty population decision-making.
When RWE Works

From Research Question to Informed Decision

We follow a structured evidence generation lifecycle that begins with the decision to be supported, builds the right study and data strategy, and delivers credible insights for stakeholder decision-making.

1

Research Question

Define the stakeholder question, decision context, target population, comparators, and endpoints.

2

Evidence Strategy & Study Design

Design the right study approach, methodology, and evidence plan.

3

Data Sourcing & Curation

Identify, curate, harmonize, and validate fit-for-purpose real-world data.

4

Analysis & Evidence Generation

Apply rigorous analytical methods to generate credible, decision-grade findings.

5

Interpretation & Reporting

Translate results into clear, stakeholder-ready evidence outputs.

6

Informed Decision

Enable confident decisions across regulatory, payer, HTA, clinical, and market access settings.

TECHNOLOGY, DATA & IQA SOLUTIONS

Technology, Data & IQA Solutions

Our evidence generation capabilities are supported by a modern data and technology foundation, strengthened by IQA’s platforms and accelerators for curation, quality, prospective data capture, protocol readiness, coding, and structured evidence workflows.

Real-World Data Sources
EHR, claims, registries, PROs, chart review, specialty datasets, and linked data environments.
Data & Analytics Foundation
Data ingestion, curation, harmonization, validation, analytics workflows, and stakeholder-ready reporting.
Evidexia
Real-world data curation, harmonization, and evidence generation workflows.
CDQOps
Data quality, validation, and evidence readiness.
InductiveEDC
Prospective studies, registries, and structured data capture.
ClinEvra
Protocol interpretation and evidence design readiness.
Aushadhi
Medical coding and terminology standardization.

Why Inductive Quotient

We combine scientific rigor, delivery expertise, and technology-enabled execution to help sponsors generate real-world evidence that is credible, decision-ready, and aligned to the needs of regulators, payers, HTA bodies, and clinical stakeholders.

Integrated RWE Expertise

Our multidisciplinary teams bring together epidemiology, biostatistics, clinical research, data management, HEOR, and regulatory-aligned thinking to design and deliver fit-for-purpose evidence.

Technology-Enabled Execution

Our evidence generation approach is strengthened by IQA solutions and accelerators that support data curation, quality oversight, analytics workflows, prospective data capture, coding, and structured evidence generation.

Decision-Grade Scientific Rigor

We focus on clear research questions, fit-for-purpose data, transparent methods, bias-aware study design, and stakeholder-ready outputs that support confident decision-making.

End-to-End Delivery Model

From evidence strategy and study design through data curation, analysis, interpretation, and reporting, we support the full evidence generation lifecycle with accountability and consistency.

Flexible Engagement Approach

Whether you need support for a targeted study, a broader evidence program, or embedded functional expertise, we adapt to your delivery model and evidence priorities.

Built for Real-World Complexity

We work across diverse real-world data sources, evolving evidence expectations, and complex stakeholder needs to generate evidence that is relevant, defensible, and actionable.

What Evidence Gap Is Slowing Your Product's Journey?

Tell us your product, your market and the decision you are trying to influence. We will design an evidence strategy that generates the specific RWE your stakeholders need to act with confidence.